March 2 (Reuters) - Heat Biologics Inc:

* HEAT BIOLOGICS - FILED PROVISIONAL PATENT APPLICATION THAT APPLIES IMMUNE SYSTEM ACTIVATING TECHNOLOGY FOR TREATING/PREVENTING INFECTION WITH SARS-COV-2 VIRUS THAT CAUSES COVID-19 Source text: (bit.ly/2VzjcJr) Further company coverage: